ArticleCureus2026
Hospitalization Rates for Phototherapy in Neonates With Transcutaneous Bilirubin (TcB) Values >5.5 mg/dL Below the Phototherapy Threshold.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionNeonatal jaundice (hyperbilirubinemia) affects over half of term infants. Although most cases are benign, some progress to severe hyperbilirubinemia, causing acute bilirubin encephalopathy or kernicterus. Early detection is essential. Total serum bilirubin (TSB) is the diagnostic standard, but invasive. Transcutaneous bilirubin (TcB) provides a reliable non-invasive screening tool. The 2022 American Academy of Pediatrics (AAP) guidelines define phototherapy thresholds but do not specify safe discharge bilirubin margins. Understanding outcomes for infants discharged near, but below, these thresholds may help guide follow-up and reduce readmissions.
objectiveTo evaluate hospitalization rates for phototherapy among neonates discharged with TcB values >5.5 mg/dL versus ≤5.5 mg/dL below the AAP phototherapy threshold and assess associations with ethnicity and feeding type. DESIGN/
methodsA retrospective cohort study of 1,848 term and near-term infants discharged from a single birth center (September 2022-September 2024) was conducted. The difference between TcB and the AAP phototherapy threshold was calculated, and infants were categorized as >5.5 mg/dL or ≤5.5 mg/dL below the threshold. The primary outcome was rehospitalization for phototherapy within one week. Analyses included chi-square and t-tests.
resultsAmong 1,848 infants, 46 (2.5%) were rehospitalized for phototherapy. Rehospitalization occurred in 7.9% of infants discharged ≤5.5 mg/dL below threshold compared with 1.2% of those >5.5 mg/dL below (
conclusionInfants discharged within 5.5 mg/dL of the phototherapy threshold have a significantly higher risk of rehospitalization for phototherapy. Ethnicity and feeding type may influence risk. Maintaining a discharge margin >5.5 mg/dL and ensuring closer follow-up for higher-risk groups may reduce preventable readmissions and improve management of neonatal jaundice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.